Pemigatinib for previously treated, locally advanced or...

  • Main
  • 2020 / 3
  • Pemigatinib for previously treated, locally advanced or...
The Lancet Oncology 2020 / 3

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Abou-Alfa, Ghassan K, Sahai, Vaibhav, Hollebecque, Antoine, Vaccaro, Gina, Melisi, Davide, Al-Rajabi, Raed, Paulson, Andrew S, Borad, Mitesh J, Gallinson, David, Murphy, Adrian G, Oh, Do-Youn, Dotan,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(20)30109-1
Date:
March, 2020
File:
PDF, 1.38 MB
english, 2020
Conversion to is in progress
Conversion to is failed